Eczema social impact

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief:  Edzel Lorraine Co, D.M.D., M.D.

## Overview

[edit | edit source]

Pruritus and constant scratching of the skin can significantly affect the social life of patient. Sleep disturbances, attention-deficit/hyperactivity disorder, headaches, daytime fatigue, and stunted growth are commonly seen in these patients and could lead to embarrassment and poor self-esteem.[1] [2] [3] [4] [5] [6] [7]

## Social Impact

[edit | edit source]

Pruritus and constant scratching of the skin can significantly affect the social life of patient. The constant itching can bring about:

* Poor self-esteem
* Embarrassment
* Suicidal ideation
* Fatigue
* Overall reduced social life.
* Females with facial eczema have been shown to have a lower quality of life using the Dermatology Life Quality Index Score. [8]

## References

[edit | edit source]

1. ↑ Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.CS1 maint: Multiple names: authors list (link)
2. ↑ Wittkowski A, Richards HL, Griffiths CE, Main CJ (2007). "Illness perception in individuals with atopic dermatitis". Psychol Health Med. 12 (4): 433–44. doi:10.1080/13548500601073928. PMID 17620207.CS1 maint: Multiple names: authors list (link)
3. ↑ Camfferman D, Kennedy JD, Gold M, Martin AJ, Winwood P, Lushington K (2010). "Eczema, sleep, and behavior in children". J Clin Sleep Med. 6 (6): 581–8. PMC 3014245. PMID 21206547.CS1 maint: Multiple names: authors list (link)
4. ↑ Silverberg JI (2016). "Association between childhood eczema and headaches: An analysis of 19 US population-based studies". J Allergy Clin Immunol. 137 (2): 492–499.e5. doi:10.1016/j.jaci.2015.07.020. PMC 5216169. PMID 26329510.
5. ↑ Silverberg JI, Paller AS (2015). "Association between eczema and stature in 9 US population-based studies". JAMA Dermatol. 151 (4): 401–9. doi:10.1001/jamadermatol.2014.3432. PMID 25493447.
6. ↑ Magin P (2013). "Appearance-related bullying and skin disorders". Clin Dermatol. 31 (1): 66–71. doi:10.1016/j.clindermatol.2011.11.009. PMID 23245976.
7. ↑ Zuberbier T, Orlow SJ, Paller AS, Taïeb A, Allen R, Hernanz-Hermosa JM; et al. (2006). "Patient perspectives on the management of atopic dermatitis". J Allergy Clin Immunol. 118 (1): 226–32. doi:10.1016/j.jaci.2006.02.031. PMID 16815160.CS1 maint: Multiple names: authors list (link)
8. ↑ Holm JG, Agner T, Clausen ML, Thomsen SF (2016). "Quality of life and disease severity in patients with atopic dermatitis". J Eur Acad Dermatol Venereol. 30 (10): 1760–1767. doi:10.1111/jdv.13689. PMID 27282435.CS1 maint: Multiple names: authors list (link)